Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2020-09-11 | 2020-12-17 | 124101 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2020-10-01 | 2021-01-07 | 125497 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2020-10-15 | 2020-11-26 | 126533 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2020-10-22 | 2020-11-12 | 126918 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2020-11-06 | 2021-01-07 | 128028 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-01-15 | 2021-05-06 | 131691 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2021-01-22 | 2021-03-18 | 132270 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2021-02-05 | 2021-03-11 | 133445 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-02-05 | 2021-04-29 | 133457 |
| ACT LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2021-02-25 | 2021-05-20 | 134730 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2021-04-21 | 2021-05-20 | 137890 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2021-05-13 | 2021-05-14 | 139303 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2021-06-03 | 2021-08-05 | 140393 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-06-24 | 2021-07-09 | 141469 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144448 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144451 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144454 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144494 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144497 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Actual shortage | 2021-08-27 | 2022-08-18 | 144701 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |